Almajali, B.; Al-Jamal, H.A.N.; Taib, W.R.W.; Ismail, I.; Johan, M.F.; Doolaanea, A.A.; Ibrahim, W.N.
Thymoquinone, as a Novel Therapeutic Candidate of Cancers. Pharmaceuticals 2021, 14, 369.
https://doi.org/10.3390/ph14040369
AMA Style
Almajali B, Al-Jamal HAN, Taib WRW, Ismail I, Johan MF, Doolaanea AA, Ibrahim WN.
Thymoquinone, as a Novel Therapeutic Candidate of Cancers. Pharmaceuticals. 2021; 14(4):369.
https://doi.org/10.3390/ph14040369
Chicago/Turabian Style
Almajali, Belal, Hamid Ali Nagi Al-Jamal, Wan Rohani Wan Taib, Imilia Ismail, Muhammad Farid Johan, Abd Almonem Doolaanea, and Wisam Nabeel Ibrahim.
2021. "Thymoquinone, as a Novel Therapeutic Candidate of Cancers" Pharmaceuticals 14, no. 4: 369.
https://doi.org/10.3390/ph14040369
APA Style
Almajali, B., Al-Jamal, H. A. N., Taib, W. R. W., Ismail, I., Johan, M. F., Doolaanea, A. A., & Ibrahim, W. N.
(2021). Thymoquinone, as a Novel Therapeutic Candidate of Cancers. Pharmaceuticals, 14(4), 369.
https://doi.org/10.3390/ph14040369